Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the jetpack-backup domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/vgbdoo6u2d7y/public_html/mcmillanresearch.com/wp-includes/functions.php on line 6121
Long Covid Coalition International Conference - Collaboration to find solutions - McMillan Research Limited
Select Page
Responsive Centered YouTube Video
Insights on long Covid symptoms, neuroimmune communication, and toxin-like peptides in Covid-19 patients.
  • Long Covid patients exhibit symptoms like brain fog, impaired quality of life, and cognitive issues. 0:08

  • Coagulation status is increased in Covid-19 patients, similar to other viral infections. 0:21

  • Guillain-Barre syndrome may manifest as a complication of Long Covid. 1:19

  • Hyposmia, a prodromal symptom, is linked to neurodegenerative diseases and previous coronavirus infections. 2:07

  • Long Covid can meet the diagnostic criteria of chronic fatigue syndrome. 3:03

  • Immune dysregulation post-viral infection can lead to microbial imbalance in the body. 3:09

  • Cholinergic system involvement in hyposmia and its association with various diseases. 4:00

  • Toxin-like peptides observed in Covid-19 patients have clinical and industrial implications. 4:10

  • The presentation focuses on the origin, recognition, and behavior of toxin-like peptides in Covid-19. 5:02

  • Collaboration among researchers and clinicians is crucial for understanding and treating Long Covid. 5:10

Insights on the impact of toxins and bacterial interactions in long-term COVID-19 symptoms.
  • Toxins from bacterial infections may contribute to prolonged symptoms in COVID-19 patients. 17:20

  • Autonomic nervous system plays a crucial role in regulating biological functions. 18:13

  • Cholinergic medications can affect nicotinic and muscarinic receptors in the body. 19:00

  • Antibiotics can impact toxin release from bacteria in COVID-19 patients. 26:42

  • Early treatment with antibiotics may reduce symptom duration in COVID-19 patients. 27:37

  • The microbiome of COVID-19 patients may produce toxins and interact with the virus. 30:16

  • The immune system must combat viral proteins and toxins in COVID-19 infections. 30:40

  • Consideration of a dual vaccine approach targeting bacteria and toxins in COVID-19. 33:43

  • Potential for engineering bacteria to resist viruses and produce beneficial proteins. 34:33

  • Importance of reducing bacterial load in wastewater to address COVID-19 spread. 35:39

Understanding the neuroscience of sickness and illness in the context of long Covid symptoms.
  • Study by Hannah Davis and team on long Covid symptoms after seven months, including fatigue and brain fog. 50:24

  • Common symptoms of long Covid include autonomic problems and persistent sickness feelings. 50:45

  • Long Covid patients often experience subjective feelings of being sick despite ongoing recovery. 50:57

Understanding the impact of long-term consequences of viral infections on the brainstem and vagus nerve.
  • Long-term consequences of viral infections can lead to sickness, autonomic problems, and pain. 51:04

  • Myalgic encephalomyelitis shares similar symptoms with long-term consequences of COVID-19. 51:31

  • Various viruses, including Ebola and Zika, have been linked to post-viral syndromes with similar symptoms. 53:00

  • The brainstem, particularly the nucleus of the solitary tract, plays a crucial role in detecting and responding to inflammation. 56:00

  • The vagus nerve serves as a communication pathway between the body and the brain, detecting inflammatory molecules and signaling illness. 1:01:07

  • Inflammation in different parts of the body can be detected by the vagus nerve, influencing the brain’s response to preserve energy during sickness. 1:02:44

Understanding the impact of immune response on the brain in long Covid
  • The vagus nerve plays a crucial role in detecting pathogens and driving the feeling of sickness locally without blood involvement. 1:03:07

  • Microbiome surveillance is a major task of the vagus nerve, initiating central illness response. 1:03:19

  • Inflammation in the brain can be measured using brain scanning techniques like PET scans. 1:03:32

  • Immune cells like monocytes and macrophages can affect the brain by crossing circumventricular organs or signaling through the vagus nerve. 1:04:05

  • Glia cells in the brain can change shape and activate in response to pathogens or inflammation, leading to the excitation of neurons. 1:06:11

  • Priming of glial cells can make the brain hypersensitive to subsequent immune responses, potentially leading to symptoms like brain fog. 1:07:05

  • Vagus nerve stimulation is being considered as a potential treatment to regulate inflammation and the anti-inflammatory reflex. 1:11:00

  • Vagus nerve stimulation devices often target the auricular branch of the vagus nerve near the ear for stimulation. 1:13:11

  • Investigating vagus nerve stimulation for long Covid patients may help regulate immune signaling and inflammation. 1:13:56

  • Active Covid-19 infection may breach the blood-brain barrier, allowing the virus to interact with the brain through the cerebral circulation. 1:14:20

Role of gut microbiome in long-term effects of COVID-19
  • Gut microbiome plays a crucial role in long COVID symptoms. 1:14:26

  • Cytokines from initial infection can breach the blood-brain barrier. 1:14:32

  • SARS-CoV-2 virus can affect the brain through neurotropism. 1:14:53

  • Choroid plexus and circumventricular organs are vulnerable to virus entry. 1:15:06

  • Fever and sickness are evolutionary defense mechanisms. 1:16:16

  • Immunosuppression may not address the root causes of long COVID symptoms. 1:18:02

  • Inflammatory signaling can lead to prolonged feelings of being unwell. 1:19:03

  • Glial priming and ongoing inflammation can contribute to neuropathic symptoms. 1:20:05

  • Toxins affecting acetylcholine signaling can impact the vagus nerve function. 1:23:01

  • Role of gut-brain axis and microbiome in long COVID needs further exploration. 1:26:09

Impact of Covid-19 on gut microbiome, brain function, and persistent infection, and strategies for therapeutic modulation.
  • Human microbiome contains about four million genes, influencing brain function and repair. 1:26:49

  • Diversity and balance in the microbiome create a healthy ecosystem. 1:34:02

  • Stress hormones can lead to dysbiosis by promoting pathogenic bacteria growth. 1:39:27

  • Inflammation and dysbiosis form a vicious cycle that needs to be addressed directly. 1:40:00

  • SARS-CoV-2 impacts gut microbiome by decreasing bacterial diversity and increasing pro-inflammatory species. 1:43:03

Impact of Gut Microbiome on Long Covid: Antibiotics, Probiotics, and Bacterial Toxins
  • Antibiotic use in acute illness and its impact on gut microbiome is controversia. 1:43:24

  • Enterococcus fecalis associated with increased mortality in long Covid patient. 1:43:52

  • Gut microbiome at disease onset predicts development of post-acute sequelae of SARS-CoV-2 (PASC. 1:44:59

  • Cytotoxic T lymphocytes play a crucial role in recovery from viral infection. 1:47:17

  • Lactobacillus consumption may increase activity of cytotoxic T lymphocyte. 1:47:34

  • Bioflavonoids may disable bacteriophage activity, impacting bacterial toxin. 1:50:03

  • Use of probiotics like Lactobacillus plantarum and soil-based organisms may be beneficial in long Covi. 1:55:06

  • Protocol focuses on enhancing healthy bacteria growth and controlling inflammation in the gu. 1:58:05

Exploring the potential role of gut bacteria and toxins in Long Covid symptoms.
  • Gut bacteria may play a role in Long Covid symptoms by producing toxins that could enter the bloodstream. 1:58:50

  • Gut dysbiosis and deficits in certain bacteria, like Enterococcus species, could impact histamine levels and muscle activation. 1:58:54

  • Histamine intolerance and mast cell activation are related but not identical issues in Long Covid patients. 1:59:24

  • Specific probiotics that break down histamine can be beneficial for those with mast cell problems or histamine intolerance. 2:00:13

  • The complexity of Long Covid involves interactions between multiple systems, making it challenging to pinpoint a single underlying cause. 2:01:44

  • Inflammatory bowel disease and celiac disease, both involving altered gut microbiomes, may influence susceptibility to Long Covid. 2:01:51

  • Neural symptoms in Long Covid may not necessarily be due to direct viral replication in the brain but could result from peripheral inflammation affecting the brain. 2:07:05

  • Research on phenolic compounds affecting macrophages in animal trials shows promise for potentially impacting microglia in the brain. 2:08:34

  • Investigations are ongoing to understand the role of gut bacteria in Long Covid and the potential impact of their toxins on symptoms. 2:10:06

  • Further experiments are needed to determine if strategies targeting gut bacteria to expel the virus and administering oral antivirals could be effective in Long Covid. 2:12:00

Discussion on microbiome impact, toxins, glial modulation, and antivirals in Long Covid management.
  • Microbiome destruction impacting body homeostasis discussed. 2:12:46

  • Fecal matter buildup and gut microbiome rebuilding suggested as a therapy. 2:12:59

  • Various mechanisms at play in Covid infection including immune responses and bacterial toxins. 2:13:22

  • Toxins from bacteria possibly used as a mechanism to destroy the virus. 2:16:27

  • Discussion on glial cell modulation with substances like low dose naltrexone and other drugs. 2:20:02

  • Importance of raising awareness about Long Covid as a disability for access to antivirals. 2:23:33

  • Challenges of antivirals reaching gut where virus replicates in Long Covid patients. 2:25:05

Insights from experts on tackling Long Covid through collaborative research and patient-centered approaches.
  • Collaboration among experts essential for tackling Long Covid effectively. 2:26:01

  • Focus on identifying the persistence of the virus and its impact on various body systems. 2:26:07

  • Exploration of natural compounds like phenolic compounds for potential antiviral properties. 2:27:27

  • Long Covid Coalition aims to bring together experts, share research, and develop patient-centered solutions. 2:29:23

  • Emphasis on understanding immune mechanisms, persistent infection, and predisposition to Long Covid. 2:35:05

  • Depletion of beneficial bacteria in the gut linked to Long Covid and potential treatment approaches. 2:37:02

  • Treatment of immune overactivity and mast cell activation shows promise in some Long Covid patients. 2:39:31

Insights on immune alterations, long COVID, and treatment strategies discussed by healthcare professionals.
  • Immune alterations in long COVID patients show high levels of cytokines like IL6 and interferon gamma. 2:40:14

  • Carlos’s work highlights the presence of infected hosts in the gut leading to recurring symptoms. 2:40:20

  • Diversity in symptomatology attributed to exposure to toxins, viral proteins, and allergic triggers. 2:40:42

  • Long COVID patients exhibit immune deficits causing excessive inflammation. 2:46:11

  • Apheresis treatment helps some patients, but ongoing endothelial inflammation may persist. 2:49:31

  • Combined treatments like ketosis, fasting, and specific medications show promise in treating long COVID. 2:50:46

  • Addressing constipation and gut health is crucial in managing long COVID symptoms. 2:52:01

Gratitude for collaboration and anticipation of future meetings.
  • Looking forward to future meeting. 2:53:33

  • Expressing gratitude and excitement for collaboratio. 2:53:33

  • Acknowledgment for organizing the gatherin. 2:53:38

  • Parting words of thanks and anticipation for the next meetin. 2:53:45